Chemoinformaics analysis of 17-HEPTADECANOLIDE
Molecular Weight | 268.441 | nRot | 0 |
Heavy Atom Molecular Weight | 236.185 | nRig | 19 |
Exact Molecular Weight | 268.24 | nRing | 1 |
Solubility: LogS | -6.609 | nHRing | 1 |
Solubility: LogP | 7.003 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 51.3314 |
nHD | 0 | BPOL | 34.7066 |
QED | 0.55 |
Synth | 2.286 |
Natural Product Likeliness | 0.426 |
NR-PPAR-gamma | 0.145 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.945 |
MDCK | 0.0000213 |
BBB | 0.197 |
PPB | 0.97092 |
VDSS | 1.821 |
FU | 0.0151311 |
CYP1A2-inh | 0.618 |
CYP1A2-sub | 0.181 |
CYP2c19-inh | 0.49 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.185 |
CYP2c9-sub | 0.922 |
CYP2d6-inh | 0.103 |
CYP2d6-sub | 0.067 |
CYP3a4-inh | 0.314 |
CYP3a4-sub | 0.06 |
CL | 5.227 |
T12 | 0.261 |
hERG | 0.313 |
Ames | 0.01 |
ROA | 0.034 |
SkinSen | 0.963 |
Carcinogencity | 0.116 |
EI | 0.978 |
Respiratory | 0.902 |
NR-Aromatase | 0.115 |
Antiviral | Yes |
Prediction | 0.626856 |